Cesium carbonate → [3-Chloro-2-fluoro-5-(4-methoxy-piperidin-1-yl)-benzyl]-carbamic acid tert-butyl ester
Reaction equation
[C:1]([O:5][C:6](=[O:18])[NH:7][CH2:8][C:9]1[CH:14]=[C:13](Br)[CH:12]=[C:11]([Cl:16])[C:10]=1[F:17])([CH3:4])([CH3:3])[CH3:2].CO[N:21]1[CH2:26][CH2:25][CH2:24][CH2:23][CH2:22]1.[C:27](=O)([O-])[O-:28].[Cs+].[Cs+].C1(P(C2C=CC=CC=2)C2C3OC4C(=CC=CC=4P(C4C=CC=CC=4)C4C=CC=CC=4)C(C)(C)C=3C=CC=2)C=CC=CC=1>C([O-])(=O)C.[Pd+2].C([O-])(=O)C>[C:1]([O:5][C:6](=[O:18])[NH:7][CH2:8][C:9]1[CH:14]=[C:13]([N:21]2[CH2:22][CH2:23][CH:24]([O:28][CH3:27])[CH2:25][CH2:26]2)[CH:12]=[C:11]([Cl:16])[C:10]=1[F:17])([CH3:4])([CH3:3])[CH3:2]Participants
6
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
was prepared according to Scheme C1 (step A) from (5-bromo-3-chloro-2-fluoro-benzyl)-carbamic acid tert-butyl ester (250 mg, 0.74 mmol), 1-methoxypiperidine (102 mg, 0.89 mmol), caesium carbonate (337 mg, 1.0 mmol), palladium (II) acetate (8.3 mg, 0.04 mmol) and 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene (30 mg, 0.05 mmol). MS (LC-MS): 373.0 [M]+; tR (HPLC conditions c): 4.68 min.
Workup
- customwas prepared
- custom4.68 min.
Sources & evidence
- ORD record
- ord-95bff7ab03e04479b07d814e2bc96cbc
- Source dataset
- uspto-grants-2015_07
- Patent number
- US09085555B2
Reaction notes
Loading…